Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is the first step in a treatment called CAR (chimeric antigen receptor) T-cell therapy. The leukapheresis market in North America market is projected to rise by USD 25 million by 2027, according to a new report by Gen Consulting Company. It is anticipated to expand at a CAGR of 7.8 percent during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into leukapheresis market in North America. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The leukapheresis market is segmented on the basis of product, application, end user, and country. The leukapheresis market is segmented as below:

By product:

  • leukapheresis devices
  • leukapheresis disposables



By application:

  • research
  • therapies



By end user:

  • blood centers
  • hospitals & infusion centers
  • enterprises
  • academic & research institutes



By country:

  • country
  • US
  • Canada
  • Mexico



The report has also analysed the competitive landscape of the leukapheresis market in North America with some of the key players being AllCells Corporation, Asahi Kasei Corporation, BioIVT LLC, Fresenius SE & Co. KGaA, Haemonetics Corporation, HemaCare Corporation (Charles River Laboratories International, Inc.), Macopharma, STEMCELL Technologies Inc., StemExpress, LLC, Terumo Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

  • To analyze and forecast the market size of the leukapheresis market in North America.
  • To classify and forecast the leukapheresis market in North America based on product, application, end user, and country.
  • To identify drivers and challenges for the leukapheresis market in North America.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the leukapheresis market in North America.
  • To identify and analyze the profile of leading players operating in the leukapheresis market in North America.



Why Choose This Report

  • Gain a reliable outlook of the leukapheresis market in North America forecasts from 2021 to 2027 across scenarios.
  • Identify growth segments for investment.
  • Stay ahead of competitors through company profiles and market data.
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.